ATE484292T1 - Chorionic gonadotropin zur behandlung des chronischen schmerzsyndroms des beckens - Google Patents

Chorionic gonadotropin zur behandlung des chronischen schmerzsyndroms des beckens

Info

Publication number
ATE484292T1
ATE484292T1 AT03808021T AT03808021T ATE484292T1 AT E484292 T1 ATE484292 T1 AT E484292T1 AT 03808021 T AT03808021 T AT 03808021T AT 03808021 T AT03808021 T AT 03808021T AT E484292 T1 ATE484292 T1 AT E484292T1
Authority
AT
Austria
Prior art keywords
pain syndrome
pelvic pain
chronic pelvic
chorionic gonadotropin
treatment
Prior art date
Application number
AT03808021T
Other languages
English (en)
Inventor
John Mcmichael
Original Assignee
Milkhaus Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Lab Inc filed Critical Milkhaus Lab Inc
Application granted granted Critical
Publication of ATE484292T1 publication Critical patent/ATE484292T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03808021T 2002-10-11 2003-05-29 Chorionic gonadotropin zur behandlung des chronischen schmerzsyndroms des beckens ATE484292T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41787802P 2002-10-11 2002-10-11
PCT/US2003/016984 WO2004032954A1 (en) 2002-10-11 2003-05-29 Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin

Publications (1)

Publication Number Publication Date
ATE484292T1 true ATE484292T1 (de) 2010-10-15

Family

ID=32094111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03808021T ATE484292T1 (de) 2002-10-11 2003-05-29 Chorionic gonadotropin zur behandlung des chronischen schmerzsyndroms des beckens

Country Status (9)

Country Link
US (1) US7101847B2 (de)
EP (1) EP1553972B1 (de)
JP (1) JP4417844B2 (de)
AT (1) ATE484292T1 (de)
AU (1) AU2003243342B2 (de)
CA (1) CA2501738C (de)
DE (1) DE60334556D1 (de)
IL (1) IL167890A (de)
WO (1) WO2004032954A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2378374T3 (es) * 2003-11-20 2012-04-11 Astellas Pharma Inc. Inhibidores de la PDE 4 para el tratamiento de la cistitis intersticial
US7605122B2 (en) 2005-07-29 2009-10-20 Millennium Medical Spa Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring
AU2006278260B2 (en) * 2005-08-08 2012-03-08 Onconon, Llc. Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
WO2008038817A1 (en) * 2006-09-25 2008-04-03 National University Corporation Tokyo University Of Agriculture And Technology Ultrasonic operation device and microtube inside system
US9707403B2 (en) 2007-12-12 2017-07-18 Neuro Code Tech Holdings, Llc Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics
WO2009089517A1 (en) 2008-01-10 2009-07-16 The Neuro-Signaling Foundation Method and system for processing cancer cell electrical signals for medical therapy
US8831738B2 (en) 2008-04-17 2014-09-09 Neuro Code Tech Holdings, Llc System and method to elicit apoptosis in malignant tumor cells for medical treatment
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
BR112015008753A2 (pt) 2012-10-18 2017-07-04 Neuralight Hd Llc tratamento de depressão e ptsd
CN103816505A (zh) * 2013-12-14 2014-05-28 潘清水 一种治疗***疾病的药物
EP3217999A4 (de) * 2014-11-12 2018-06-20 Neuralight HD, LLC Verfahren zur linderung und behandlung chronischer schmerzen mit hcg
US11154238B2 (en) 2015-08-07 2021-10-26 Electroceuticals, Llc Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
ES2158887T3 (es) * 1992-12-18 2001-09-16 Merck & Co Inc Procedimiento para tratar la prostatitis cronica con 17 beta-n-terc-butilcarbamoil-4-aza-5 alfa-androst-1-en-ona.
US5610136A (en) * 1996-01-30 1997-03-11 Milkhaus Laboratory, Inc. Method for treatment of benign prostatic hypertrophy
AU3993899A (en) * 1998-05-18 1999-12-06 Merck & Co., Inc. Method for treating or preventing chronic nonbacterial prostatitis and prostatodynia
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
ATE476663T1 (de) * 2001-08-20 2010-08-15 Univ New Jersey Med Spiegel der müllerschen inhibierenden substanz und ovarialreaktion

Also Published As

Publication number Publication date
AU2003243342A1 (en) 2004-05-04
US20040072731A1 (en) 2004-04-15
JP4417844B2 (ja) 2010-02-17
EP1553972A4 (de) 2008-02-13
CA2501738A1 (en) 2004-04-22
EP1553972B1 (de) 2010-10-13
AU2003243342B2 (en) 2009-12-17
US7101847B2 (en) 2006-09-05
DE60334556D1 (de) 2010-11-25
WO2004032954A1 (en) 2004-04-22
JP2006504735A (ja) 2006-02-09
CA2501738C (en) 2012-07-24
EP1553972A1 (de) 2005-07-20
IL167890A (en) 2010-11-30

Similar Documents

Publication Publication Date Title
IL167890A (en) Use of a chorionic gonadotropin in the preparation of a medicament for treating a chronic pelvic pain syndrome
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
NZ595262A (en) Use of il-23 and il-27 antagonists to treat autoimmune ocular inflammatory disease
NO20034549D0 (no) Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
EP1712239A3 (de) Interleukin-1 Inhibitoren zur Behandlung von Erkrankungen
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
DE602005018763D1 (de) Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
MY151032A (en) Treatment of tnf? related disorders
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
ATE362770T1 (de) Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen
MX2007005523A (es) Metodo para el tratamiento preventivo de alergias mediante administracion en mucosas de una vacuna contra alergias.
EA200101089A1 (ru) Новый способ лечения
DE602005026276D1 (de) Myricitrin verbindungen zur behandlung von schlafstörungen
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
ATE389651T1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
EA200800766A1 (ru) Ингибиторы pi3k для лечения эндометриоза
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
EA200400302A1 (ru) Способ лечения первичной бессонницы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties